Hurun Logo

India’s Bio-Economy likely to touch $150bn by 2025

by Rajesh Ravi - July 28, 2022

Key Highlights India is the global leader in the supply of DPT, BCG, measles, and COVID vaccines. Indian companies are setting up facilities for nearly 5.5 billion doses of COVID-19 vaccines. The procurement cost by the GAVI alliance for COVID-19 the vaccine will be INR 250 ($3) per dose. At that rate Indian companies will…

You're reading as a guest.

Log in or create a free Hurun Research account to continue reading.

Create an account.